Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/jRCT2080222091
jRCT2080222091UnknownPhase 2

M518101 phase 2b study in plaque psoriasis patients - comparison study 3 -

Maruho Co.,Ltd.0 sitesStarted: TBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Primary Endpoint
-
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Intervention Model
Multi-center, placebo-controlled, randomized, double-blind, parallel-group, dose-finding study

Eligibility Criteria

Ages
16age old over to No limit (—)
Sex
All

Inclusion Criteria

  • •Patients diagnosed with plaque psoriasis.
  • •Outpatient.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

-

severity of plaque psoriasis

Secondary Outcomes

No secondary outcomes reported

Investigators

Similar Trials

Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 2Plaque psoriasis
JPRN-jRCT2080221434Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 1Plaque psoriasis
JPRN-jRCT2080221433Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 3Plaque psoriasis
JPRN-jRCT2080222091Maruho Co.,Ltd.
Unknown
Phase 3
M518101 phase III study in plaque psoriasis patientsPlaque psoriasis
jRCT2080222894Maruho Co.,Ltd.
Unknown
Phase 3
M518101 phase III study in plaque psoriasis patientsPlaque psoriasis
JPRN-jRCT2080222894Maruho Co.,Ltd.